Nánási Péter Pál

1.

Imre, L., Nánási, P. P. i., Benhamza, I., Enyedi, K. N., Mocsár, G., Bosire, R., Hegedűs, É., Niaki, E. F., Csóti, Á., Darula, Z., Csősz, É., Póliska, S., Scholtz, B., Mező, G., Bacsó, Z., Timmers, H. T. M., Kusakabe, M., Balázs, M., Vámosi, G., Ausio, J., Cheung, P., Tóth, K., Tremethick, D., Harata, M., Szabó, G.: Epigenetic modulation via the C-terminal tail of H2A.Z.
Nat Comms. 15 (1), 1-21, (article identifier: 9171), 2024.

doi DEA WoS Scopus

Journal metrics:

D1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

D1 Chemistry (miscellaneous)

D1 Physics and Astronomy (miscellaneous)

2.

Bosire, R., Fadel, L., Mocsár, G., Nánási, P. P. i., Sen, P., Sharma, A. K., Naseem, M. U., Kovács, A., Kugel, J., Kroemer, G., Vámosi, G., Szabó, G.: Doxorubicin impacts chromatin binding of HMGB1, Histone H1 and retinoic acid receptor.
Sci. Rep. 12 (1), 1-14, (article identifier: 8087), 2022.

doi DEA WoS Scopus

Journal metrics:

D1 Multidisciplinary

3.

Imre, L., Niaki, E. F., Bosire, R., Nánási, P. P. i., Nagy, P., Bacsó, Z., Hamidova, N., Pommier, Y., Jordan, A., Szabó, G.: Nucleosome destabilization by polyamines.
Arch. Biochem. Biophys. 722, 1-11, (article identifier: 109184), 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry

Q1 Biophysics

Q2 Molecular Biology

4.

Káldy, J., Patakiné Várkonyi, E., Fazekas, G., Nagy, Z., Jakabné Sándor, Z., Bogár, K., Kovács, G., Molnár, M., Lázár, B., Goda, K., Gyöngy, Z., Ritter, Z., Nánási, P. P. i., Horváth, Á., Ljubobratović, U.: Effects of Hydrostatic Pressure Treatment of Newly Fertilized Eggs on the Ploidy Level and Karyotype of Pikeperch Sander lucioperca (Linnaeus, 1758).
Life (Basel). 11 (12), 1-11, (article identifier: 1296), 2021.

doi DEA

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q2 Ecology, Evolution, Behavior and Systematics

Q2 Paleontology

Q3 Space and Planetary Science

5.

Fülöp, G. Á., Oláh, A., Csípő, T., Kovács, Á., Pórszász, R., Veress, R., Horváth, B., Nagy, L., Bódi, B., Fagyas, M., Helgadottir, S. L., Bánhegyi, V., Juhász, B., Bombicz, M., Priksz, D., Nánási, P. P. i., Merkely, B., Édes, I., Csanádi, Z., Papp, Z., Radovits, T., Tóth, A.: Omecamtiv mecarbil evokes diastolic dysfunction and leads to periodic electromechanical alternans.
Basic Res. Cardiol. 116 (1), 24, (article identifier: 24), 2021.

doi DEA WoS Scopus

Journal metrics:

Q1 Cardiology and Cardiovascular Medicine

Q1 Physiology

Q1 Physiology (medical)

6.

Henn, L., Szabó, A., Imre, L., Román, Á., Ábrahám, A., Vedelek, B., Nánási, P. P. i., Boros, I. M.: Alternative linker histone permits fast paced nuclear divisions in early Drosophila embryo.
Nucleic Acids Res. 48 (16), 9007-9018, 2020.

doi DEA WoS Scopus

Journal metrics:

D1 Genetics

7.

Nánási, P. P. i., Imre, L., Firouzi Niaki, E., Bosire, R., Mocsár, G., Türk-Mázló, A., Ausio, J., Szabó, G.: Doxorubicin induces large-scale and differential H2A and H2B redistribution in live cells.
PLoS One. 15 (4), 1-23, (article identifier: 0231223), 2020.

doi DEA WoS Scopus

Journal metrics:

D1 Multidisciplinary

8.

Firouzi Niaki, E., Van Acker, T., Imre, L., Nánási, P. P. i., Tarapcsák, S., Bacsó, Z., Vanhaecke, F., Szabó, G.: Interactions of Cisplatin and Daunorubicin at the Chromatin Level.
Sci. Rep. 10 (1), 1-12, (article identifier: 1107), 2020.

doi DEA WoS Scopus

Journal metrics:

D1 Multidisciplinary

9.

Bosire, R., Nánási, P. P. i., Imre, L., Dienes, B., Szöőr, Á., Türk-Mázló, A., Kovács, A., Seidel, R., Vámosi, G., Szabó, G.: Intercalation of small molecules into DNA in chromatin is primarily controlled by superhelical constraint.
PLoS One. 14 (11), e0224936, 2019.

doi DEA WoS Scopus

Journal metrics:

D1 Multidisciplinary

10.

Hegedűs, É., Kókai, E., Nánási, P. P. i., Imre, L., Halász, L., Jossé, R., Antunovics, Z., Webb, M. R., El Hage, A., Pommier, Y., Székvölgyi, L., Dombrádi, V., Szabó, G.: Endogenous single-strand DNA breaks at RNA polymerase II promoters in Saccharomyces cerevisiae.
Nucleic Acids Res. 46 (20), 10649-10668, 2018.

doi DEA WoS Scopus

Journal metrics:

D1 Genetics

11.

Nánási, P. P. i., Komáromi, I., Gaburjakova, M., Almássy, J.: Omecamtiv Mecarbil: a Myosin Motor Activator Agent with Promising Clinical Performance and New in vitro Results.
Curr. Med. Chem. 25 (15), 1720-1728, 2018.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry

Q1 Drug Discovery

Q2 Molecular Medicine

Q1 Organic Chemistry

Q2 Pharmacology

12.

Nánási, P. P. i., Komáromi, I., Almássy, J.: Perspectives of a myosin motor activator agent with increased selectivity.
Can. J. Physiol. Pharmacol. 96 (7), 676-680, 2018.

doi DEA WoS Scopus

Journal metrics:

Q2 Medicine (miscellaneous)

Q2 Pharmacology

Q3 Physiology

Q3 Physiology (medical)

13.

Nagy, L., Gődény, I., Nánási, P. P. i., Leskó, Á., Balogh, L., Bánhegyi, V., Bódi, B., Csípő, T., Csongrádi, A., Fülöp, G. Á., Kovács, Á., Lódi, M., Papp, Z.: A szív pozitív inotróp támogatása a miozin-aktivátor hatású omecamtiv-mecarbil segítségével.
Cardiol. Hung. 47 (1), 69-76, 2017.

DEA

14.

Nánási, P. P. i., Imre, L., Horváth, A., Halász, L., Szántó, A., Kimura, H., Székvölgyi, L., Nagy, L., Szabó, G.: Breaking good: +1 nucleosome destabilizationby nicking.
FEBS J. 284 (Suppl.), 221, 2017.

doi DEA

15.

Imre, L., Simándi, Z., Horváth, A., Fenyőfalvi, G., Nánási, P. P. i., Firouzi Niaki, E., Hegedűs, É., Bacsó, Z., Weyemi, U., Mauser, R., Ausio, J., Jeltsch, A., Bonner, W., Nagy, L., Kimura, H., Szabó, G.: Nucleosome stability measured in situ by automated quantitative imaging.
Sci Rep. 7 (1), 1-15, 2017.

doi DEA WoS Scopus

Journal metrics:

D1 Multidisciplinary

16.

Nánási, P. P. i., Gaburjakova, M., Gaburjakova, J., Almássy, J.: Omecamtiv mecarbil activates ryanodine receptors from canine cardiac but not skeletal muscle.
Eur. J. Pharmacol. 809, 73-79, 2017.

doi DEA

Journal metrics:

Q2 Pharmacology

17.

Nánási, P. P. i., Váczi, K., Papp, Z.: The myosin activator omecamtiv mecarbil: a promising new inotropic agent.
Can. J. Physiol. Pharmacol. 94 (10), 1033-1039, 2016.

doi DEA

Journal metrics:

Q2 Medicine (miscellaneous)

Q3 Pharmacology

Q3 Physiology

Q3 Physiology (medical)

18.

Nánási, P. P. i., Nánási, P. P.: Problems with class 3 antiarrhythmic agents: conclusions of the past - perspectives of the future.
Curr. Topics Pharmacol. 15 (2), 11-18, 2011.

DEA

Journal metrics:

Q4 Pharmacology

Q4 Pharmacology (medical)

Nánási Péter Pál

Publication list